Comparison between Three Promising ß-emitting Radionuclides, (67)Cu, (47)Sc and (161)Tb, with Emphasis on Doses Delivered to Minimal Residual Disease

PURPOSE: Radionuclide therapy is increasingly seen as a promising option to target minimal residual disease. Copper-67, scandium-47 and terbium-161 have a medium-energy β(- )emission which is similar to that of lutetium-177, but offer the advantage of having diagnostic partner isotopes suitable for...

Descripción completa

Detalles Bibliográficos
Autores principales: Champion, Christophe, Quinto, Michele A., Morgat, Clément, Zanotti-Fregonara, Paolo, Hindié, Elif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955060/
https://www.ncbi.nlm.nih.gov/pubmed/27446495
http://dx.doi.org/10.7150/thno.15132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955060/
https://www.ncbi.nlm.nih.gov/pubmed/27446495
http://dx.doi.org/10.7150/thno.15132

Ejemplares similares